Admetsys Corp.


Admetsys is pioneering the future of critical care through high-precision automation, adapting to individual patient needs and implementing clinician-set goals automatically. Their innovative clinical robotics system is designed for blood analysis and metabolic control in critical care and surgery, aiming to improve patient outcomes and reduce clinical workload.

Industries

biotechnology
health-care
medical-device

Nr. of Employees

small (1-50)

Admetsys Corp.

Boston, New York, United States, North America


Products

Clinical automation controller for closed-loop metabolic management

Bedside automation controller that ingests biosensor data, maintains a patient-specific metabolic model in real time, and autonomously delivers optimized insulin and dextrose infusions.

Extracorporeal continuous blood diagnostics (cartridge-based)

Disposable cartridge and extracorporeal sensing system that provides continuous whole-blood measurements of multiple analytes (glucose, lactate, temperature, hematocrit) for up to several days with no net blood loss.


Services

Clinical validation and trial execution

Design and conduct of clinical studies for device performance assessment, including metrics for glucose control, hypoglycemia prevention, and time to normoglycemia.

Expertise Areas

  • Automated glycemic control in critical care
  • Continuous extracorporeal blood diagnostics
  • Closed-loop clinical automation
  • Real-time physiological modeling and AI for patient-specific therapy
  • Show More (4)

Key Technologies

  • Closed-loop insulin/dextrose infusion control
  • Continuous extracorporeal whole-blood biosensing
  • Cartridge-based multi-analyte sensors
  • Real-time AI-driven metabolic modeling
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.